Comparison between low and high radioactive iodine (131I) reablation dose in patients with papillary thyroid cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comparison between low and high radioactive iodine (131I) reablation dose in patients with papillary thyroid cancer

Published:2015-02 Issue:2 Volume:36 Page:114-119
ISSN:0143-3636
Container-title:Nuclear Medicine Communications
language:en
Short-container-title:

Author:

M. El-Refaei Sherif,W. Yassin Shereen,Salman Khaled,Al Munshy Tarek,Al-Ezzi Manal,M. Al-Sayed Yasser,Abd Elkareem Husseni Maha

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Reference20 articles.

1. Cancer statistics, 2009.;Jemal;CA Cancer J Clin,2009

2. US features of thyroid malignancy: pearls and pitfalls.;Hoang;Radiographics,2007

3. . American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.;Cooper;Thyroid,2009

4. Extent of surgery affects survival for papillary thyroid cancer.;Bilimoria;Ann Surg,2007

5. . Radioiodine thyroid remnant ablation in patients with differentiated thyroid carcinoma (DTC): prospective comparison of long-term outcomes of treatment with 30, 60 and 100mCi.;Kukulska;Thyroid Res,2010

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of Different Radioiodine Doses for Post-ablation Therapy of Thyroid Remnants: A Systematic Review;Iranian Journal of Pharmaceutical Research;2022-05-14

2. Clinical outcomes and associated factors of radioiodine-131 treatment in differentiated thyroid cancer with cervical lymph node metastasis;Oncology Letters;2018-03-15

3. Re-ablation I-131 activity does not predict treatment success in low- and intermediate-risk patients with differentiated thyroid carcinoma;Endocrine;2016-01-06

4. Thyroglobulin value in patients surgically treated for differentiated thyroid carcinoma;Srpski arhiv za celokupno lekarstvo;2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3